In addition, studies have shown that hnRNP U has the ability to deplete the sensitivity of bladder uroepithelial cancer cells to cisplatin, and inhibition of hnRNP U may be a potential treatment for cisplatin-resistant bladder cancer [120]. The gene discussed is HNRNPU; the disease is urinary bladder cancer.